SFS
EBS icon

Sowell Financial Services’s Emergent Biosolutions EBS Stock Holding History

Sowell Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-141
Closed -$9K – 1114
2021
Q1 		$9K Buy
+141
New +$14.4K ﹤0.01% 2358

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sowell Financial Services's EBS Position: Q2 2021 in Review

Sowell Financial Services sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 141 shares — an estimated $9K sold.

Sowell Financial Services first reported a position in EBS in Q1 2021 and held it in 1 quarter. The position peaked at $9K in Q1 2021. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Sowell Financial Services reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 141 Emergent Biosolutions shares in Q2 2021, an estimated $9K.
  • Sowell Financial Services first reported a position in Emergent Biosolutions in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Emergent Biosolutions position peaked at $9K in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.